TORONTO, Dec. 5, 2017 /CNW/ - Bernard Fortier, CEO, Tetra Bio-Pharma Inc. (TBP), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange, to open the market. Tetra Bio-Pharma biopharmaceutical company that is engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements. Tetra Bio-Pharma Inc. commenced trading on TSX Venture Exchange on August 16, 2017.

Bernard Fortier, CEO, Tetra Bio-Pharma Inc. (TBP), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange, to open the market. Tetra Bio-Pharma biopharmaceutical company that is engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements. Tetra Bio-Pharma Inc. commenced trading on TSX Venture Exchange on August 16, 2017. (CNW Group/TMX Group Limited)

SOURCE TMX Group Limited

Copyright 2017 Canada NewsWire

Tetra Bio Pharma (TSXV:TBP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Tetra Bio Pharma Charts.
Tetra Bio Pharma (TSXV:TBP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Tetra Bio Pharma Charts.